Literature DB >> 27777535

Open Conversion after Aortic Endograft Infection Caused by Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae.

Nunzio Montelione, Danilo Menna, Pasqualino Sirignano, Laura Capoccia, Wassim Mansour, Francesco Speziale.   

Abstract

A 62-year-old man presented with fever, abdominal pain, and malaise 13 months after emergency endovascular aortic repair. Computed tomographic angiograms showed a periprosthetic fluid and gas collection, so infection was diagnosed. Open conversion was performed, involving endograft explantation and in situ aortic reconstruction. Cultures and the explanted prosthesis were positive for carbapenemase-producing Klebsiella pneumoniae, resistant to colistin. Because of the sparse data on endograft infections caused by this pathogen, we placed the patient on an empiric double-carbapenem regimen for 4 weeks. Symptomatic recovery occurred after 21 days. On the 30th day, we deployed a stent to treat a new pseudoaneurysm. Three years later, the patient had no signs of persistent or recurrent infection. We think that this is the first report of aortic endograft infection caused by colistin-resistant, carbapenemase-producing K. pneumoniae.

Entities:  

Keywords:  Anti-bacterial agents/therapeutic use; Klebsiella pneumoniae/drug effects/growth & development; aortic aneurysm, abdominal/surgery; bacterial infections/drug therapy/etiology/microbiology; blood vessel prosthesis implantation/adverse effects; drug therapy, combination; endovascular procedures/adverse effects; postoperative complications; prosthesis-related infections/diagnosis/drug therapy/microbiology/surgery; treatment outcome

Mesh:

Substances:

Year:  2016        PMID: 27777535      PMCID: PMC5067045          DOI: 10.14503/THIJ-15-5265

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  34 in total

Review 1.  Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Authors:  G L Daikos; A Markogiannakis
Journal:  Clin Microbiol Infect       Date:  2011-06-02       Impact factor: 8.067

Review 2.  The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines.

Authors:  Elliot L Chaikof; David C Brewster; Ronald L Dalman; Michel S Makaroun; Karl A Illig; Gregorio A Sicard; Carlos H Timaran; Gilbert R Upchurch; Frank J Veith
Journal:  J Vasc Surg       Date:  2009-10       Impact factor: 4.268

Review 3.  Current technology for the treatment of infection following abdominal aortic aneurysm (AAA) fixation by endovascular repair (EVAR).

Authors:  L Capoccia; G Mestres; V Riambau
Journal:  J Cardiovasc Surg (Torino)       Date:  2014-02-11       Impact factor: 1.888

4.  Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.

Authors:  K Kontopoulou; E Protonotariou; K Vasilakos; M Kriti; A Koteli; E Antoniadou; D Sofianou
Journal:  J Hosp Infect       Date:  2010-06-17       Impact factor: 3.926

5.  Graft infection after endovascular abdominal aortic aneurysm repair.

Authors:  Adriana Laser; Nichole Baker; John Rectenwald; Jon L Eliason; Enrique Criado-Pallares; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2011-02-02       Impact factor: 4.268

6.  Infective etiology affects outcomes of late open conversion after failed endovascular aneurysm repair.

Authors:  Danilo Menna; Laura Capoccia; Pasqualino Sirignano; Andrea Esposito; Massimo Rossi; Francesco Speziale
Journal:  J Endovasc Ther       Date:  2015-02       Impact factor: 3.487

7.  A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms.

Authors:  Monique Prinssen; Eric L G Verhoeven; Jaap Buth; Philippe W M Cuypers; Marc R H M van Sambeek; Ron Balm; Erik Buskens; Diederick E Grobbee; Jan D Blankensteijn
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

8.  Late conversion of aortic stent grafts.

Authors:  Rebecca L Kelso; Sean P Lyden; Brett Butler; Roy K Greenberg; Matthew J Eagleton; Daniel G Clair
Journal:  J Vasc Surg       Date:  2009-01-09       Impact factor: 4.268

9.  Bacterial and clinical criteria relating to the outcome of patients undergoing in situ replacement of infected abdominal aortic grafts.

Authors:  F Speziale; L Rizzo; E Sbarigia; M F Giannoni; M Massucci; C Maraglino; E Santoro; P Fiorani
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-02       Impact factor: 7.069

10.  Randomized comparison of cold blood and cold crystalloid renal perfusion for renal protection during thoracoabdominal aortic aneurysm repair.

Authors:  Scott A Lemaire; Marisa M Jones; Lori D Conklin; Stacey A Carter; Monique D Criddell; Xing Li Wang; Steven A Raskin; Joseph S Coselli
Journal:  J Vasc Surg       Date:  2008-11-22       Impact factor: 4.268

View more
  3 in total

1.  First case of aorto-bi-iliac endograft thrombotic infection by Listeria monocytogenes: A case report.

Authors:  Enrico M Zardi; Nunzio Montelione; Vincenzo Catanese; Teresa Gabellini; Marco Caricato; Domenico M Zardi; Francesco Spinelli; Francesco Stilo
Journal:  Exp Ther Med       Date:  2022-06-06       Impact factor: 2.751

2.  Thoracic aorta graft infection by avibactam-resistant KPC-producing K. pneumoniae treated with meropenem/vaborbactam: a case report and literature review.

Authors:  Alessandra Belati; Roberta Novara; Davide Fiore Bavaro; Andrea Procopio; Cecilia Fico; Lucia Diella; Federica Romanelli; Stefania Stolfa; Adriana Mosca; Francesco Di Gennaro; Annalisa Saracino
Journal:  Infez Med       Date:  2022-06-01

Review 3.  Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy.

Authors:  Alireza FakhriRavari; Brenda Simiyu; Taylor Morrisette; Yewande Dayo; Jacinda C Abdul-Mutakabbir
Journal:  Drugs Context       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.